chr5-176943347-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001199298.2(UIMC1):c.1585G>A(p.Glu529Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001199298.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UIMC1 | NM_001199298.2 | c.1585G>A | p.Glu529Lys | missense_variant | Exon 10 of 15 | ENST00000511320.6 | NP_001186227.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UIMC1 | ENST00000511320.6 | c.1585G>A | p.Glu529Lys | missense_variant | Exon 10 of 15 | 1 | NM_001199298.2 | ENSP00000421926.1 | ||
UIMC1 | ENST00000506128.5 | c.1087G>A | p.Glu363Lys | missense_variant | Exon 10 of 15 | 1 | ENSP00000427480.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251120Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135706
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461610Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727088
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1585G>A (p.E529K) alteration is located in exon 10 (coding exon 9) of the UIMC1 gene. This alteration results from a G to A substitution at nucleotide position 1585, causing the glutamic acid (E) at amino acid position 529 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at